Techulon is leading the next generation of disease treatment through development of safe and effective treatments for drug resistant infections. The company uses a proven method to defeat bacteria at the genomic level. Unlike current antibiotics on the market, the drugs that are derived from Techulon’s approach are potent and not susceptible to resistance.Techulon's enabling technology is a robust platform that allows for delivery of nucleic acids for a variety of therapeutic applications. The company has recently been awarded a $1.9M contract from DARPA to advance its antimicrobial platform to fight both Gram-negative as well as Gram-positive bacteria. Using a novel informatics approach, the company has identified new gene targets and is developing antimicrobial therapeutics for broad applications.
Company Details
- Employees
- 2
- Founded
- -
- Address
- 2200 Kraft Drive,
- Phone
- 5404439254
- in****@****lon.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- techulon.com
- Keywords
- Synthetic polymers for life science applications and drug delivery, transfection reagents, cell therapy delivery, biodegradable transfection reagents.
- HQ
- Blacksburg, VA
Techulon Inc. Questions
Techulon Inc.'s helpline number is 5404439254
Techulon Inc.'s website is techulon.com
Techulon Inc.'s LinkedIn profile is https://www.linkedin.com/company/techulon-inc.
Techulon Inc. has
2 employees.
View email and phone details for 2
employees at Techulon Inc..
Techulon Inc.'s industry is
Biotechnology Research
Techulon Inc.'s top competitors are
Toltech,
Vaxdyn,
Therakind Limited,
Tech Dilmeth,
Telum Therapeutics,
Trius,
Torus Biosystems,
Utility Therapeutics (Acquired By Alembic Pharmaceuticals Inc.),
Zentek Ltd.,
Toltec Sa.
Techulon Inc.'s support email address is inquiries@techulon.com
Techulon Inc.'s categories are Biotechnology Research
Techulon Inc.'s founding year is 2006
